Alignment Healthcare financials
$7.91−0.25%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.33B | $1.23B | $975.8M | $993.7M | $1.01B | $918.0M | $669.6M | $692.4M | $681.3M | $628.6M | $459.0M | $450.2M |
| Gross profit | $171.9M | $135.8M | $86.3M | $125.7M | $124.5M | $97.1M | $54.7M | $79.0M | $76.0M | $55.4M | $459.0M | $450.2M |
| Gross margin | 13.0% | 11.1% | 8.8% | 12.6% | 12.4% | 10.6% | 8.2% | 11.4% | 11.2% | 8.8% | 100.0% | 100.0% |
| Operating income | $33.1M | $6.9M | -$47.3M | $7.7M | $13.7M | -$14.3M | -$54.2M | -$19.5M | -$18.4M | -$41.1M | -$48.3M | -$36.2M |
| Net income | $36.6M | $11.4M | -$11.0M | $3.7M | $15.7M | -$9.1M | -$31.1M | -$26.4M | -$24.0M | -$46.5M | -$47.2M | -$35.0M |
| Net margin | 2.8% | 0.9% | −1.1% | 0.4% | 1.6% | −1.0% | −4.6% | −3.8% | −3.5% | −7.4% | −10.3% | −7.8% |
| Diluted EPS | $0.17 | $0.05 | $-0.06 | $0.02 | $0.07 | $-0.05 | $-0.16 | $-0.14 | $-0.13 | $-0.25 | $-0.25 | $-0.19 |
| EBITDA | $40.9M | $14.7M | -$39.5M | $15.7M | $20.7M | -$6.7M | -$47.4M | -$11.8M | -$10.7M | -$36.2M | -$48.3M | -$32.3M |
| Operating cash flow | -$17.3M | $128.7M | -$50.4M | $144.6M | $29.1M | $16.6M | -$8.7M | $26.2M | $23.5M | -$6.2M | -$187.5M | $6.0M |
| Free cash flow | -$27.5M | $121.3M | -$55.4M | $139.1M | $21.1M | $8.4M | -$18.0M | $16.9M | $11.8M | -$17.4M | -$198.1M | -$3.6M |
| Diluted shares | 215.0M | 213.1M | 180.0M | 208.9M | 209.5M | 193.6M | 191.9M | 191.4M | 190.9M | 189.0M | 188.4M | 187.3M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $693.5M | $705.6M | $575.8M | $618.1M | $470.3M | $446.2M |
| Short-term investments | $8.3M | $20.7M | $28.4M | $26.0M | $33.5M | $33.4M |
| Total debt | $324.1M | $323.6M | $323.2M | $322.7M | $322.3M | $321.9M |
| Total assets | $1.28B | $1.26B | $1.07B | $1.10B | $1.00B | $895.6M |
| Total liabilities | $1.01B | $1.05B | $886.5M | $940.7M | $859.2M | $786.6M |
| Shareholders' equity | $265.1M | $206.9M | $179.3M | $161.9M | $141.0M | $109.0M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology